Martin Shkreli, the former pharmaceutical executive known as ‘Pharma Bro’, has faced another legal setback as the U.S. Supreme Court denied his appeal to overturn a $64.6 million repayment order. The decision reaffirms his liability for the profits gained through a fraudulent scheme and bars him from the pharmaceutical industry for life.
Martin Shkreli, known as ‘Pharma Bro’, has been ordered by a US federal judge to turn over all copies of the rare Wu-Tang Clan album ‘Once Upon a Time in Shaolin’. This comes after the album’s current owner, PleasrDAO, claimed that Shkreli illegally distributed copies of the album. The judge also ordered Shkreli to provide a full accounting of all copies he has and any revenue generated from distributing the album.
